DOJ

DOJ Encouraging Self-Disclosure as Guilty Pleas in Corporate Crimes Down 70%
Risk & Compliance

DOJ Encouraging Self-Disclosure as Guilty Pleas in Corporate Crimes Down 70%

Only 90 guilty pleas by corporations were submitted in 2021, dropping from 304 in 2000, per a U.S. Sentencing Commission report.
By Adam Zaki | October 12, 2022
Read More
The DOJ Targets Fraud: 5 Things to Know
Fraud

The DOJ Targets Fraud: 5 Things to Know

The Department of Justice is redoubling efforts to pursue corporate wrongdoing and prosecute high-level executives.
By Russ Banham | February 18, 2022
Read More
Large Deals Meet Resistance
Legal

Large Deals Meet Resistance

If the DOJ has its way, more mega-mergers will be abandoned or wind up in court.
By Matt Heller | February 7, 2022
Read More
DOJ Lays Out a Path to Reduced Corporate Penalties
Risk & Compliance

DOJ Lays Out a Path to Reduced Corporate Penalties

A new Justice Department policy gives defense counsel a framework for winning reduced monetary penalties for fiscally poor client companies.
By David McCann | November 14, 2019
Read More
DOJ Puts C-Suite Execs in Crosshairs
Risk Management

DOJ Puts C-Suite Execs in Crosshairs

DOJ: “While pursuit of criminal and civil remedies against corporations is important, we should always focus on the individuals responsible for misconduct."
By Vincent Ryan | July 10, 2019
Read More
Workplace Class Actions Soared in 2017
Risk & Compliance

Workplace Class Actions Soared in 2017

But employers can expect better outcomes this year, as the Trump Administration gains a stronger foothold with its pro-employer orientation.
By David McCann | January 16, 2018
Read More
Executives Investigated Under FCPA Can Fear Less
Strategy

Executives Investigated Under FCPA Can Fear Less

Altering an unwritten policy, the DOJ eases pressure on companies to fire executives involved in FCPA wrongdoing.
By Alice Hsieh and Daniel Patrick Wendt | January 9, 2017
Read More
SEC Settles Two Huge FCPA Cases
Risk & Compliance

SEC Settles Two Huge FCPA Cases

Petrochemical company Braskem, its parent Obebrecht, and Teva Pharmaceutical Industries will pay a combined $4 billion.
By Sean Allocca | December 22, 2016
Read More
How to Prevent Corruption from Marring a Merger
Management Accounting

How to Prevent Corruption from Marring a Merger

Failing to identify a corrupt M&A target could spawn serious problems for an acquirer’s finances and reputation.
By Bryan S. Schultz and David W. Simon | March 13, 2015
Read More